Acumen Pharmaceuticals, Inc. (ABOS) 宣布，其将在2026年举行的阿尔茨海默病与帕金森病国际会议（International Conference on Alzheimer’s and Parkinson’s Diseases）上，公布公司在阿尔茨海默病治疗领域取得的最新研究进展。
此次展示将重点聚焦于该公司在研疗法的最新数据，标志着其在攻克这一神经退行性疾病道路上迈出的关键一步。业界期待这些数据能为阿尔茨海默病的治疗带来新的希望。
Acumen Pharmaceuticals, Inc. (ABOS) 宣布，其将在2026年举行的阿尔茨海默病与帕金森病国际会议（International Conference on Alzheimer’s and Parkinson’s Diseases）上，公布公司在阿尔茨海默病治疗领域取得的最新研究进展。
此次展示将重点聚焦于该公司在研疗法的最新数据，标志着其在攻克这一神经退行性疾病道路上迈出的关键一步。业界期待这些数据能为阿尔茨海默病的治疗带来新的希望。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.